UNSPSC 51281620: Paromomycin

This classification denotes an aminoglycoside antibiotic with the molecular formula C23H45N5O14, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 61JJC8N5ZK, chemically known as streptamine, o-2,6-diamino-2,6-dideoxy-beta-l-idopyranosyl-(1-3)-o-beta-d-ribofuranosyl-(1-5)-o-(2-amino-2-deoxy-alpha-d-glucopyranosyl-(1-4))-2-deoxy- but generally known as paromomycin, which bears US NIH Compound Identifier 24176.

UNSPSC 51281620 Paromomycin is a Commodity code for a specific pharmaceutical product, but the recent state and local contract opportunities posted under it do not involve paromomycin procurement. The Illinois Department of Public Health awarded a piggyback pharmaceutical warehouse contract through MMCAP Infuse to Chartwell Rx LLC in August 2026 for Doxycycline Hyclate 100mg tablets and Ciprofloxacin Hydrochloride 500mg tablets—both antibiotics unrelated to paromomycin—with a total award value of $2,999,999.11 over 12 months plus two renewal options. Seminole County, Florida issued an IFB in June 2026 for annual procurement of 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems, also outside the code's stated scope. The mismatch between the code's nominal product and the actual recent solicitations suggests that state and local procurement offices are either tagging these opportunities incorrectly or using the paromomycin code as a generic pharmaceutical Commodity placeholder.

Because the recent opportunities do not reflect actual paromomycin demand, the code shows little actionable signal for vendors targeting paromomycin supply. The issuing bodies—a state health department and a county health authority—represent the typical buyers of pharmaceutical products under broad pharmaceutical codes, but the specific drug categories they are actively procuring (broad-spectrum antibiotics and emergency-response medications) diverge from the paromomycin designation. Illinois and Florida account for the documented recent activity, but without confirmed paromomycin solicitations, geographic spread and repeat-buyer characterization cannot be reliably established from this source.